Astaxanthin: a xanthophyll carotenoid

Astaxanthin is a red pigment from the carotenoid family, more precisely from the xanthophyll subgroup, which comprises the oxygen-containing carotenoids. Its systematic name is 3,3-dihydroxy-beta,beta-carotene-4,4-dione and its molecular formula is C40H52O4. The molecule consists of a long polyene chain with conjugated double bonds, flanked by two ionone rings that each carry a hydroxyl group and a keto group.

This arrangement of polar groups at both ends of a non-polar chain is the structural feature most often discussed in the literature. It allows the molecule to span a lipid bilayer, with the polar ring ends at the two membrane surfaces and the chain in the hydrophobic interior. Beta-carotene, which lacks these oxygen functions, cannot adopt that orientation. The conjugated chain is also the chemical basis for the colour and for the radical-scavenging behaviour measured in laboratory assays.

Isomers and chemical forms

Astaxanthin has two chiral centres, so three optical isomers exist: 3S,3S, 3R,3R and the meso form 3R,3S. Haematococcus pluvialis produces almost exclusively the 3S,3S form, the yeast Xanthophyllomyces dendrorhous mainly 3R,3R, and chemical synthesis gives a mixture of all three. In algal biomass astaxanthin is present largely as mono- and diesters with fatty acids, while synthetic material and the yeast product are unesterified. Geometric isomers of the all-trans and cis forms also differ between sources. These differences matter for analysis, for stability and for regulatory classification.

Natural occurrence

The principal natural source is the freshwater microalga Haematococcus pluvialis, also listed as Haematococcus lacustris. Under favourable conditions the alga is green and motile; under stress, such as nitrogen depletion, high light or salinity, it forms thick-walled resting cells and accumulates astaxanthin to several percent of its dry weight, which turns the culture deep red.

Astaxanthin gives salmon, trout, shrimp, krill and lobster their colouring. These animals cannot synthesise it and obtain it through the food chain from algae and zooplankton. Flamingos owe their pink plumage to carotenoids from their diet of algae and crustaceans. The yeast Xanthophyllomyces dendrorhous, formerly Phaffia rhodozyma, and the bacterium Paracoccus carotinifaciens also produce it.

Production

Commercial astaxanthin comes from three routes. Cultivation of Haematococcus pluvialis takes place in two stages, a green growth phase followed by an induction phase under stress, in tubular photobioreactors or open ponds; the biomass is then disrupted and extracted, often with supercritical carbon dioxide, to give an oleoresin. Fermentation of Xanthophyllomyces dendrorhous is the second route. The third and quantitatively largest is chemical synthesis, whose output goes almost entirely into aquaculture feed to colour farmed salmon and trout. Synthetic and natural material differ in isomer composition, and supplements for human consumption in the EU are based on the algal source.

Regulatory status in the European Union

Astaxanthin-rich oleoresin from Haematococcus pluvialis is a novel food in the EU. The European Food Safety Authority published a safety assessment in 2020 and derived an acceptable daily intake of 0.2 milligrams per kilogram of body weight per day. For an adult of 70 kilograms this corresponds to 14 milligrams per day, and EFSA noted that a maximum of 8 milligrams per day in supplements for adults would stay within the ADI when background dietary intake from fish and seafood is taken into account. Supplements for children and adolescents were not covered by this assessment. Synthetic astaxanthin is authorised in the EU as a feed additive for salmon, trout and ornamental fish, with maximum contents laid down in feed legislation. No health claim on astaxanthin has been authorised under Regulation (EC) No 1924/2006.

Bioavailability

Astaxanthin is lipophilic, and absorption from the gut is limited and variable. Pharmacokinetic studies report higher plasma concentrations when it is taken with a fat-containing meal than when taken fasting, and formulation work concentrates on lipid carriers, emulsions, liposomes and cyclodextrin complexes. Esterified astaxanthin from algae is hydrolysed in the gut before absorption. Measured plasma concentrations after oral intake are in the nanomolar to low micromolar range, which is far below the concentrations used in many cell culture experiments; this gap is the central caveat when laboratory results are discussed.

What studies have examined

  • Laboratory antioxidant assays. In chemical test systems such as singlet oxygen quenching and lipid peroxidation assays, astaxanthin shows high activity, and comparisons with vitamin C, vitamin E and beta-carotene are frequently cited. These are measurements in the test tube, and the ranking they produce depends on the assay chosen. Whether they say anything about processes in the human body is unresolved, given the plasma concentrations reached.
  • Skin. Small randomised trials, generally with 4 to 12 milligrams per day over 8 to 16 weeks, have measured skin moisture, transepidermal water loss, elasticity and wrinkle depth by instrument, and some have measured the minimal erythema dose after UV exposure. Participant numbers were mostly below 100, several trials were industry-funded, and the measured differences were small.
  • Eye. Trials in people with eye strain from screen work have used questionnaires and measurements of accommodation. The trials are small, mostly from a single research group, and outcome measures vary.
  • Exercise. Studies in trained and untrained participants have measured time trial performance, substrate utilisation and markers of muscle damage. Results are inconsistent, with some trials reporting differences and others none.
  • Cardiovascular and metabolic parameters. Trials have measured blood lipids, blood pressure and markers of oxidative stress. Sample sizes are small, durations short and findings mixed.
  • Neurological research. Work on neurodegenerative conditions is at the cell culture and rodent stage. Human data are absent.

The quantities given describe study protocols and are not intake recommendations.

Safety

No serious adverse effects have been reported in the published trials at the doses used. A visible and harmless effect at higher intake is an orange tinge of the skin, analogous to carotenoderma from beta-carotene. Data in pregnancy and breastfeeding are insufficient, and supplementation is therefore not advised in these situations. People with allergies to algae or seafood should take the source material into account. Interactions have been discussed for substances metabolised by cytochrome P450 enzymes, based on laboratory data, and people taking medicines should consult a physician before intake. The EFSA acceptable daily intake applies to all sources combined.

Industrial and other uses

  • Aquaculture. Quantitatively the largest application, as a feed additive for colouring farmed salmon and trout.
  • Animal feed. In feed for ornamental fish and poultry.
  • Food industry. As a colouring foodstuff and as an ingredient in food supplements.
  • Cosmetics. In topical formulations, where the regulatory framework is cosmetic law rather than food law.

Open questions

  • Absorption after oral intake is low and variable, and standardised methods of measurement are lacking.
  • The relationship between laboratory antioxidant capacity and anything measurable in humans is unresolved.
  • Natural production remains comparatively costly, which drives work on cultivation and extraction methods.
  • Quality control and declaration of isomer composition in commercial products are not uniformly standardised.
  • Long-term trials in humans are absent.

Summary

Astaxanthin is a well characterised xanthophyll whose unusual membrane orientation and high laboratory antioxidant capacity explain the research interest. Most of the published work is in cell culture and in animals; human trials are small, short and heterogeneous. Its status in the EU is that of a novel food with a defined acceptable daily intake and no authorised health claim.